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Demonstration That Circulating la,25-Dihydroxyvitamin D
Is Loosely Regulated in Normal Children
PAULA H. STERN, ASHBY B. TAYLOR, NORMAN H. BELL, and SOL EPSTEIN,
Department of Pharmacology, Northwestern University Medical School,
Chicago, Illinois 60611; Veterans Administration Medical Center and
Departments of Pediatrics, Medicine and Pharmacology, Medical University
of South Carolina, Charleston, South Carolina 29403; Department of Medicine,
Indiana University Medical School, Indianapolis, Indiana 46202

A B S T RA C T The effects of vitamin D, 2.5 mg
(100,000 U)/d for 4 d, on serum calcium, serum 25hydroxyvitamin D (25-OHD) and serum la,25-dihydroxyvitamin D (la,25(OH)2D) were compared in
24 normal adults and 12 normal children. The daily
dose of vitamin D was 1,500 U/kg body wt in children
weighing <45 kg. Vitamin D increased mean serum
calcium from 9.5±0.1 to 9.8±0.1 mg/dl (P < 0.05),
increased mean serum phosphorus from 4.6±0.1 to
5.0±0.1 mg/dl (P < 0.01), increased mean serum
25-OHD from 25±3 to 34±4 ng/ml (P < 0.001), and
increased mean serum la,25(OH)2D from 34±3 to 42±4
pg/ml (P < 0.02) in children. In contrast, vitamin D
increased mean serum 25-OHD from 18±2 to 39±6
ng/ml (P < 0.001) and did not change mean serum
calcium (9.4±0.1 vs. 9.5±0.1 mg/dl), mean serum
phosphorus (4.0±0.1 vs. 4.1±0.1 mg/dl), or mean
serum la,25(OH)2D (31±2 vs. 29±3 pg/ml) in adults.
Mean serum la,25(OH)2D was significantly higher
after vitamin D in children than in adults (P < 0.02).
These results provide evidence that circulating
la,25(OH)2D is not as tightly regulated in children as it is in adults. This difference in regulation
could account in part for the higher values for serum
la,25(OH)2D observed in children.

sistently higher in normal children and adolescents
than in normal adults (1-6). It is known that growth
hormone secretion is increased in children and adolescents (7) and that intestinal absorption of calcium
increases in response to administration of growth
hormone (5, 8). Thus, one explanation could be that the
production of la,25(OH)2D is regulated by growth
hormone. Short-term studies do not support this possibility (3, 5). In one investigation, for example,
administration of growth hormone to children with
deficiency of the hormone increased intestinal absorption of calcium and reduced serum la,25(OH)2D (5).
On the other hand, preliminary long-term studies
provide evidence that growth hormone may increase
the sensitivity of the kidney to parathyroid hormone
and thereby augment circulating la,25(OH)2D (9).
We previously demonstrated tight regulation of circulating la,25(OH)2D in normal adults given pharmacologic doses of vitamin D (10, 11). One mechanism
which could account for higher values for serum
la,25(OH)2D in children is that production of the
metabolite is not closely regulated. The present studies
were carried out to examine this hypothesis. The
response of circulating la,25(OH)2D to challenge
with vitamin D was compared in children and adults.

METHODS
INTRODUCTION
24 normal adult subjects, 10 men and 14 women, ranging in
Previous findings indicate that serum values for age from 21 to 56 yr, and 12 normal children, 5 boys and
7 girls, ranging in age from 21 mo to 17 yr, were studied.
la,25-dihydroxyvitamin D (1a,25(OH)2D)' are con- All
except one of the adults were between 21 and 49 yr
of age. They were hospitalized in the Clinical Research
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obtained from each of the adults and from one or both parents
of each of the children. Each of them was given a constant
daily diet estimated to contain 400 mg/d of calcium and
900 mg/d of phosphorus. Daily fluid intake was constant.
Vitamin D, 2.5 mg (100,000 U)/d for 4 d, was given as a single
moming dose. The daily dose of vitamin D was 1,500 U/kg in
children who weighed <45 kg. Fasting blood samples were
obtained on the 1st d before vitamin D and again on the 5th d,
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TABLE I

Effects of Vitamin D2 on Serum Calcium, Phosphorus, Creatinine, 25-OHD,
and 1 a,25(OH)2D in Normal Children and Adults
Serum

Children (12)
Control
Vitamin D
P value
Adults (24)
Control
Vitamin D
P value

Calcium

Phosphorus

Creatinine

25-OHD*

la,25(OH)2D

mgldl

mg/dl

mgldl

ng/ml

pg/ml

9.5±0.1
9.8±0.1
<0.05

4.6±0.1
5.0±0.1
<0.01

0.7±0.1
0.7±0.1
NS

25±3
34±4
<0.001

34±3
42±4
<0.02

9.4±0.1
9.5±0.1
NS

4.0±0.1
4.1±0.1
NS

0.9±0.1
0.9±0.1
NS

18±2
39±6
<0.001

31±2
29+3
NS

Results are given as mean±SE.
* Serum 25-OHD was measured in 21 normal adults before vitamin D
and in 17 normal
adults after vitamin D.
24 h after the last dose of the vitamin, for determination of
calcium, phosphorus, creatinine, 25-hydroxyvitamin D (25OHD), and la,25(OH)2D. Serum calcium (12, 13), phosphorus (14), and creatinine (15, 16) were determined by
automated methods. 24-h urines were collected from the children and analyzed for calcium (13).
Serum 25-OHD was measured in triplicate at two dilutions by the protein-binding method, with sera from vitamin
D-deficient rats (17) after extraction and LH-20 chromatography (10). The normal range in our laboratory is from 8 to
61 ng/ml.
Serum la,25(OH)2D was measured by bioassay (10, 11).
With few exceptions, the two samples from each subject
were measured in the same assay. The mean value in normal
adult subjects is 32+2 pg/ml and the normal range is from
12 to 55 pg/ml (n = 33). The 95% confidence values (mean +2
SD) are 13-52 pg/ml. Interassay variation is 9.1% (n = 17).
Serum samples were obtained from other normal outpatient
subjects, both children and adults, after overnight fast for
determination of parathyroid hormone (PTH). Serum immunoreactive PTH was measured by radioimmunoassay
with antiserum from chicken 77125 at a final concentration of
1:10,000 (10, 18).
Student's t test was used to determine the significance of
differences between paired and unpaired samples (19). A
Hewlett-Packard calculator (model 9815 A, Hewlett Packard
Co., Palo Alto, Calif.) was used to make these calculations
and to determine the correlation coefficient.

RESULTS

Vitamin D2 was given for 4 d to each subject. The daily
dose averaged 1,482±48 U/kg body wt/d in the children and 1,549±56 U/kgld in the adults. The results are
summarized in Table I. In children, vitamin D produced significant increases in mean serum calcium,
serum phosphorus, serum 25-OHD, and serum la,25(OH)2D. The increases in mean serum 25-OHD and
serum la,25(OH)2D averaged 36 and 24%, respectively. In contrast, vitamin D significantly increased
mean serum 25-OHD and did not change mean serum

calcium, serum phosphorus, or serum la,25(OH)2D in
the adults. The increase in mean serum 25-OHD
averaged 116% and was greater in adults than in children. Despite the smaller increment in mean serum
25-OHD in children, mean serum la,25(OH)2D was
significantly higher after vitamin D in them than in the
adults (P < 0.02). In children the correlation between
serum 25-OHD and serum la,25(OH)2 was not significant. After vitamin D, serum la,25(OH)2D either
increased or did not change (+ 10%) in 10 of the 12
children (84%) whereas it either decreased or did not
change in 16 of the 24 adults (75%). In children the
increase in serum la,25(OH)2D was not related to age,
sex, or age at onset of puberty.
Serum immunoreactive PTH averaged 314±157
pg/ml (mean+SD) in a group of 28 normal children
(age range: 8-19 yr) and 281±119 pg/ml in a group of
85 normal adults (age range: 21-49 yr). These values
are not significantly different (P > 0.2).
Urinary calcium did not change in any of the children during the 4 d of vitamin D administration
(data not shown).
DISCUSSION

Our findings show an unequivocal "impairment" in
regulation of circulating la,25(OH)2D in a group of
normal children in response to a challenge with pharmacologic doses of vitamin D. There were proportional
increases in the concentrations of la,25(OH)2D and of
the precursor, 25-OHD, which were associated with
significant increases in serum calcium and phosphorus.
The results are in clear contrast to those obtained
in a group of adults who demonstrated no change in
mean serum la,25(OH)2D, mean serum calcium, or
Serum 1 a,25-Dihydroxyvitamin D in Children
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mean serum phosphorus, in response to challenge
with vitamin D (10, 11).
It is unlikely that the enhanced response of serum
la,25(OH)2D in children is related to an increase in the
concentration of circulating PTH. Whereas mean
serum immunoreactive PTH was higher in a group of
normal children than in a group of normal adults, the
difference was not statistically significant. As noted already, however, preliminary evidence in long-term
studies in children suggests that growth hormone may
increase serum 1a,25(0H)2D by enhancing the renal
response to PTH (9).
The findings in children are qualitatively similar
to those we reported previously in patients with
sarcoidosis and normal calcium metabolism. When
challenged with the same dose of vitamin D, these
individuals exhibited a mean twofold increase in
serum la,25(OH)2D (11). Also, glucocorticoids decreased serum la,25(OH)2D in children (20) and,
when given for 8 d, lowered serum la,25(OH)2D in
patients with sarcoid who were normocalcemic (21),
but did not alter serum la,25(OH)2D in normal adults
(21). When given for 14 d to adults, glucocorticoids
increased serum la,25(OH)2D and lowered the fractional intestinal absorption of calcium (22).
The question of extrarenal production of la,25(OH)2D
was raised in sarcoid because of the demonstration
of increased serum la,25(OH)2D (which correlated
with the serum calcium) and suppressed serum
immunoreactive PTH in a patient with the disorder
who had undergone bilateral nephrectomy (23). In
this regard, recent preliminary studies showed that
a positive correlation existed between serum 25-OHD
and serum la,25(OH)2D in children with chronic renal
disease who were undergoing treatment with 25-OHD3
only when the glomerular filtration rate was c 25
ml/min (24). The findings in these patients could be
interpreted to mean that there is extrarenal synthesis
of la,25(OH)2D that is not closely regulated. These
and the present observations suggest that children
may have either a different control mechanism
for regulation of renal synthesis of the metabolite
as compared to adults, extrarenal production of
la,25(OH)2D, or some combination of these possibilities. Our findings do not allow us to distinguish
among these alternatives.
Whatever the mechanism, our results showing lack of
tight regulation of circulating la,25(OH)2D provide
a possible explanation for the higher serum values of
this metabolite in normal children and adolescents as
compared to adults (1-6).
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